baber/WOPTO huggingface dataset:
Patent AU-2062692-A (AU)
Title: Iron type golf club head having a single sole runner
IPC: A63B53/04
Filed: 1992-07-28
Abstract: An iron type golf club head (10) having a single runner (28) centrally located on the bottom sole (22) in a heel-to-toe direction under the center of gravity. The runner (28) extends outwardly from the sole (22) and is progressively thicker in a direction from the leading edge (32) to the rear edge (33) for engaging the ground surface prior to the bottom (22) sole when a golf club is used during the execution of a golf shot. <IMAGE>
Patent AU-2135997-A (AU)
Title: Method and composition for hair removal
Inventor: BEN-HUR EHUD
IPC: A61K8/00
Filed: 1997-02-24
Abstract: The present invention provides a method for removing hair from a selected skin area comprising the steps of (a) applying a liposome composition comprising a photosensitizer to the selected skin area so that the composition is introduced into hair follicle ducts of the skin area, wherein the photosensitizer is present in the composition in an amount effective to undergo a reaction and damage the hair follicles upon application to the skin area of light at an appropriate wavelength, energy and duration to penetrate the skin and activate the photosensitizer; (b) removing from the skin area substantially all of the liposome composition which is not introduced into the hair follicle ducts; and (c) applying light to the skin area at an appropriate wavelength, energy and duration to penetrate the skin and cause the photosensitizer to undergo a reaction to damage the hair follicles. The present invention also provides a composition useful for hair removal.
Patent AU-2289101-A (AU)
Title: Adhesive alpha-olefin inter-polymers
Inventor: KARANDINOS ANTHONY GEORGE
IPC: C09J123/16
Filed: 2000-12-21
Abstract: An adhesive blend is described that can include a semi-crystalline copolymer of propylene and at least one comonomer selected from the group consisting of ethylene and at least one C 4  to C 20  ±-olefin, the copolymer having a weight average molecular weight (Mw) from about 15,000 to about 200,000; an melt index (MI) from about 7 dg/min to about 3000 dg/min as measured by ASTM D 1238(B), and a (Mw/Mn) of approximately 2. Various production processes are also described. Also described are adhesive compositions and methods for making adhesive compositions having polymers or polymer blends with melt flow rates (MFRs) equal to and above 250 dg/min. at 230NC. Certain specific embodiments of the invention involve the use of a free radical initiator, e.g., a peroxide.
Patent AU-2649795-A (AU)
Title: Process for recovering polyhydroxyalkanoates using air classification
Inventor: NODA ISAO
IPC: C08G63/78
Filed: 1995-05-25
Abstract: The present invention relates to a process for recovering polyhydroxyalkanoate from a biological source material comprising the polyhydroxyalkanoate, the process comprising: a) comminuting the biological source material; b) air classifying the biological source material such that the polyhydroxyalkanoate particles are separated from other components of the biological source material; and c) recovering the polyhydroxyalkanoate.
Patent AU-2680000-A (AU)
Title: Cementitious compositions
Inventor: KENDALL KEVIN
IPC: C04B7/52
Filed: 2000-02-22
Abstract: A method of producing a curable cementitiuous composition comprises admixing: a) particles of cement, and b) an aqueous suspension containing a plasticiser and also particles of a pozzolan having a mean particle size which is at most one half that of the mean particle size of the cement, and allowing or causing the admixture to cure.
Patent AU-2785899-A (AU)
Title: Synthesis of epothilones, intermediates thereto and analogues therof
Inventor: DANISHEFSKY SAMUEL J
IPC: C07D417/06
Filed: 1999-02-24
Abstract: The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof, useful in the treatment of cancer and cancer which has developed a multidrug-resistant phenotype. Also provided are intermediates useful for preparing said epothilones.
Patent AU-2806597-A (AU)
Title: Human DNase II
Inventor: BAKER KEVIN P
IPC: C12P21/08
Filed: 1997-04-23
Abstract: This invention relates to a novel human deoxyribonuclease, referred to as human DNase II. The invention provides nucleic acid sequences encoding human DNase II, thereby enabling the production of human DNase II by recombinant DNA methods in quantities sufficient for clinical use. The invention also relates to pharmaceutical compositions and diagnostic and therapeutic uses of human DNase II.
Patent AU-2849300-A (AU)
Title: Methods and assay kits for detecting mononuclear cell phenotype
Inventor: BARBERA-GUILLEM EMILIO
IPC: G01N33/569
Filed: 2000-01-13
Abstract: A method for screening for a pro-tumor immune response according to the present invention, the method comprises: contacting a clinical sample with one or more detector molecules for detecting, and then determining the amount of, mononuclear cell phenotype in the sample; and (b) comparing the amount of mononuclear cell phenotype determined in the sample to a reference value for the mononuclear cell phenotype; wherein a significant difference in the amount of mononuclear cell phenotype determined as compared to the reference value may be an indicator of the presence of a pro-tumor immune response. Also provided are assay kits for determining an amount of mononuclear cell phenotype in performing the methods according to the present invention.
Patent AU-2891701-A (AU)
Title: Process for recovering monomeric units of a nylon from whole carpet
Inventor: COURAGE ANTONIUS JOHANNES FRAN
IPC: B29B17/02
Filed: 2000-12-01
Abstract: The invention relates to a process for recovering monomeric units of a nylon from whole carpet comprised of fibres comprised of said nylon and a backing comprised of non-nylon components, which fibres are bound to the backing, the whole carpet containing between 15 and 35 wt.% of said nylon, which process comprises the steps of   a) mechanically separating the whole carpet into a beneficiated carpet mixture which contains between 35 and 55 wt.% of said nylon and into a depleted carpet mixture b) exposing the beneficiated carpet mixture to conditions at which depolymerization of said nylon is effected.
Patent AU-3087900-A (AU)
Title: Noise suppression in a mobile communications system
Inventor: CAVANDER HANS
IPC: H04B7/26
Filed: 1999-12-03
Abstract: A method and apparatus are disclosed for suppressing bumblebee noise in a mobile communications system, whereby a digital processor (18) associated with a speech coder (17) in a mobile phone (16) receives the incoming stream of speech samples and performs a Fast Fourier Transform on the incoming sample stream. A priori knowledge about where in the frequency spectrum the bumblebee noise occurs is advantageously used to determine just which frequency samples in the Fast Fourier Transform the bumblebee noise has enhanced. The noise at these frequencies is then suppressed (110) by, for example, interpolating between two neighboring frequency samples to suppress the noise in the samples therebetween.
Patent AU-3113395-A (AU)
Title: Electromechanical connection device
Inventor: BULLINGER ACHIM
IPC: H01R13/703
Filed: 1995-07-18
Abstract: PCT No. PCT/EP95/02811 Sec. 371 Date Sep. 29, 1997 Sec. 102(e) Date Sep. 29, 1997 PCT Filed Jul. 18, 1995 PCT Pub. No. WO96/31923 PCT Pub. Date Oct. 10, 1996The invention concerns an electromechanical connection device comprising a switching device which can be connected to a current source via power supply contacts and comprises switching magnets. A tripping device. provided with tripping magnets, can be connected to the switching device. Switching magnets are thus moved from a rest position, against a restraining force, into an operating position, the contact between pairs of contacts and hence the electrical connection between the switching device and the tripping device being established. The switching magnets and the tripping magnets are provided with a special code. A plurality of switching magnets in the outer peripheral area of an operating slide are disposed as segments at a distance from one another. An identical number of tripping magnets with opposite polarity are likewise arranged as segments in the same peripheral area as the switching magnets in the tripping device.
Patent AU-3156493-A (AU)
Title: A pen-shaped syringe
IPC: A61M5/20
Filed: 1992-11-30
Abstract: PCT No. PCT/DK92/00359 Sec. 371 Date May 20, 1994 Sec. 102(e) Date May 20, 1994 PCT Filed Nov. 30, 1992 PCT Pub. No. WO93/10839 PCT Pub. Date Jun. 10, 1993A pen-shaped syringe comprises a first part containing a dose setting and driving mechanism from which a piston rod is advanced by a carrier to actuate a piston of a reservoir in a second part. The first and second parts are coupled together by a bayonet coupling, wherein the bayonet coupling element of the second part has members for rotating a piston rod guide mounted on the bayonet coupling element of the first part. The piston rod determines the rotational position of the piston rod which rotational position again determines the engagement between the carrier and the piston rod.
Patent AU-3367289-A (AU)
Title: Near-infrared analysis of tissue fat percentage
Inventor: ROSENTHAL ROBERT D
IPC: A61B10/00
Filed: 1989-03-13
Abstract: Method and apparatus for determining percent fat in a body wherein near-infrared radiation (16, 16') is transmitted into the body to achieve optical interactance between the body and the near-infrared radiation. Optical absorption by the body at one or more wavelengths of the near-infrared radiation is measured (28, 29). The measured absorption of near-infrared radiation is utilized to quantitatively determine the fat content of the body. Data on a plurality of physical parameters of the body, such as height, weight, exercise level, sex, race, waste-to-hip measurement and arm circumference, can be utilized along with the measured near-infrared absorption in the quantitative determination of body fat content.
Patent AU-3388195-A (AU)
Title: Local area method arrangement
Inventor: LAINE SEPPO
IPC: H05B37/02
Filed: 1995-09-08
Abstract: PCT No. PCT/FI95/00489 Sec. 371 Date Mar. 10, 1997 Sec. 102(e) Date Mar. 10, 1997 PCT Filed Sep. 5, 1995 PCT Pub. No. WO96/08096 PCT Pub. Date Mar. 14, 1996A local area network arrangement is taught for implementing a control system. The local area network arrangement includes a low-voltage bus composed of a cable pair, functioning as a common transmission path of the network, a plurality of connection units connecting the bus to operating devices to be controlled by the network, and a control unit common to the operating devices, connected to the bus, for controlling the operating devices. Data is transmitted in the network both from the control unit to the connection units, and from the connection units to the control unit. More particularly, the control units send to the bus a constant-frequency carrier signal whereby a number of cycles of the carrier signal form a transmission frame, in which each connection unit corresponds to a particular cycle of the frame. Also, for at least part of the cycles of the transmission frame, one half of each cycle is used for transmitting data to one specific connection unit, and the other half is used for transmitting power to all connection units.
Patent AU-3410797-A (AU)
Title: Assembly for retaining optical components
Inventor: ABUL-HAJ N ALAN
IPC: G02B6/36
Filed: 1997-06-25
Abstract: An assembly useful for retaining optical components such as lenses, optical filters and the like includes a block having a cavity and a pair of retainers received in the cavity. In certain embodiments, the cavity is cylindrical and each retainer has a semi-cylindrical configuration. Each retainer preferably includes integrally molded deformable ribs that shift the optical components when the retainers are closed to a position such that the optical axis of each component is collinear with the central axis of the optical chamber and the retainer cavity.
Patent AU-3582800-A (AU)
Title: Methods for generating phosphorylation site-specific immunological reagents
Inventor: ANDERSON CARL W
IPC: C07K16/00
Filed: 2000-01-25
Abstract: The present invention provides methods for generating phosphorylation site-specific immunological reagents. More specifically, a phosphopeptide mimetic is incorporated into a polypeptide in place of a phosphorylated amino acid. The polypeptide is used as antigen by standard methods to generate either monoclonal or polyclonal antibodies which cross-react with the naturally phosphorylated polypeptide. The phosphopeptide mimetic preferably contains a non-hydrolyzable linkage from the appropriate carbon atom of the amino acid residue to a phosphate group. A preferred linkage is a CF2 group. Such a linkage is used to generate the phosphoserine mimetic F2Pab, which is incorporated into a polypeptide sequence derived from p53 to produce antibodies which recognize a specific phosphorylation state of p53. A CF2 group linkage is also used to produce the phosphothreonine mimetic F2Pmb, and to produce the phosphotyrosine mimetic, F2Pmp.
Patent AU-3592589-A (AU)
Title: Apparatus for collecting, assembling and inserting printery products
Inventor: HONEGGER WERNER
IPC: B65H39/02
Filed: 1989-06-01
Abstract: Racks (18) are provided on the conveying chain (16) which can be driven in rotation in the direction (F) of the arrow. Arranged on the left and on the right of the conveying chain (16) are guide plates (24, 24') attached to a frame (22). One of these guide plates (24) also forms a part of the one side flank of the V-shaped receiving part (12). Provided in the gap between the bottom end of this guide plate (24) and the short flank (32) of the bent guide plate (34) is the conveying chain (28), which can be driven in rotation in the conveying direction (F), the carrier parts (30), attached to it, projecting into the receiving part (12). At the feed points, printing products (10, 10') for assembly can be placed astride the racks (18) or introduced into the receiving part (12) for insertion or collating. These printing products (10, 10') are then guided either from the racks (14, 20) or the carrier parts (30) to the next feed point in each case or to the downstream removal point. 
<IMAGE>
Patent AU-3647895-A (AU)
Title: Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients
Inventor: WARREN KENNETH G
IPC: A61K38/08
Filed: 1995-10-20
Abstract: Human myelin basic protein (h-MBP) has a molecular weight of 18.5 KD and contains 170 amino acid residues. Synthetic peptides ranging in length from about 8 to 25 residues and covering the entire length of the protein have been produced. Antibodies to h-MBP (anti-MBP) were found to be neutralized by the synthetic peptides, in vitro, which span the h-MBP from about amino acid residue 61 to about amino acid residue 106. The peptides, which cover both the amino (about residues 1 to 63) and carboxy (about residues 117 to 162) terminals of h-MBP did not neutralize purified anti-MBP. Intrathecal administration of peptide MBP75-95, either as a single dose, or as repeated injections for periods up to 10 weeks, produced complete binding-neutralization of free (F) anti-MBP with no change in bound (B) levels. A control peptide MBP35-58 had no effect on F or B anti-MBP levels. Intravenous administration of MBP75-95 resulted in significant decline of F and B CSF anti-MBP levels over a period of one month. Administration of MBP synthetic peptides to MS patients either intrathecally or intravenously did not have any adverse neurological effects and systemic complications did not occur. The MBP epitope for MS anti-MBP has been localized to an area between Pro85 and Pro96.
Patent AU-3731697-A (AU)
Title: Melatonin 1a receptor gene regulatory regions and uses thereof
Inventor: REPPERT STEVEN M
IPC: C12N15/85
Filed: 1997-07-17
Abstract: Disclosed are DNAs encoding melatonin 1a receptor gene promoter regions, recombinant polypeptides expressed from such DNAs, and methods of using such expression constructs to screen for promoter activators or inhibitors. Transcriptional activators are useful as therapeutics to reentrain endogenous melatonin rhythms as a means of treating circadian rhythm disorders in humans and control reproductive cycles in seasonally breeding animals. Transcriptional inhibitors are useful as therapeutics to control the initiation or timing of puberty in humans.
Patent AU-3810685-A (AU)
Title: Inspecting pipe interiors using fiberoptics
Inventor: FITZGERALD CHARLES S
IPC: G02B23/26
Filed: 1985-01-25
Abstract: A probe (10) for inspecting the inner surface of a tube (40) utilises a group of large diameter optical fibres (12) as a light source and an annular ring (14) of smaller diameter optical fibres as interceptors of the reflected light. A pair of plano-convex lenses (16) focuses a light beam (42) emanating from the group of large diameter optical fibres (12) onto a reflective ball bearing (18) or a concave cone (32) causing a circumferential band (44) to be illuminated on the inner surface of the tube (40). Light from the band (44) is intercepted by the optical fibres within the annular ring (14) and is transmitted therethrough. The transfer of light from the band (44) to the annular ring (14) can be optimised by bevelling the end of the optical fibres (14) within the annular ring.
Patent AU-3904285-A (AU)
Title: Steel casting using a co2 gas protective shroud
Inventor: SAVARD GUY
IPC: B22D27/00
Filed: 1985-02-21
Abstract: Molten steel, normally exposed to an atmosphere of air, is protected against pick-up of impurities by placing carbon dioxide gas in such quantities and in such proximity to the surface to cause dissociation of the carbon dioxide at a rate which furnishes an atmosphere of carbon monoxide and gives off a negligible amount of oxygen to the steel, thus providing a gas barrier or shroud isolating the steel from the surrounding atmosphere and preventing pick-up therefrom of oxygen, nitrogen or hydrogen. This method may be applied to protecting steel being transferred from a ladle to a mold, or from a ladle to a tundish and from the tundish to a mold in continuous casting. In a method where a number of shrouding operations are carried out in series, carbon dioxide vapor, under pressure, is bled, in increments, from a storage vessel containing a body of liquid carbon dioxide in overlying ullage space containing vapor. Each increment is superheated, after it leaves the vessel, and is ultimately expanded and dispersed at ambient temperature to form the shroud. As each increment of vapor is removed from the vessel, it is replaced by withdrawing liquid carbon dioxide, vaporizing it and returning it to the ullage space.
Patent AU-4005893-A (AU)
Title: Antibacterial antiplaque mouthwash composition
Inventor: DUCKENFIELD JOAN
IPC: A61K8/34
Filed: 1993-06-04
Abstract: An oral composition mouthwash or liquid dentifrice containing an aqueous vehicle acceptable vehicle including an alcohol, a substantially water-insoluble noncationic antibacterial antiplaque agent, such as 2,4,4'-trichloro-2'-hydroxy-diphenyl ether (triclosan) wherein the antiplaque agent is entirely dissolved in the solvent and the weight ratio of water to alcohol is in excess of about 10;1.
Patent AU-4128893-A (AU)
Title: Connecting joint for electric furnace electrodes
Inventor: TAHON BERNARD
IPC: H05B7/14
Filed: 1993-06-17
Abstract: Coupling for the rigid and stationary end-connection of graphite or carbon electrodes whose ends contain a sleeve tube with an internal threading into which is screwed a double-threaded connector or nipple pierced with holes acting as reservoirs containing a solid and electrically conductive cement, characterised in that at least one of the said reservoirs is filled with a synthetic cement consisting of a thermosetting resin, which, in the presence of a catalyst, melts at a temperature greater than 60 DEG C in order to form a liquid phase with a viscosity below 2500 centipoises between 90 DEG C and 120 DEG C and to polymerise at a temperature greater than or equal to 120 DEG C. <IMAGE>
Patent AU-4182697-A (AU)
Title: Use of prostate tumor inducing gene for detection of cancer cells
Inventor: FISHER PAUL B
IPC: C12Q1/68
Filed: 1997-09-05
Abstract: This invention provides a method for detecting cancer cells in a sample comprising detection of the expression of a Prostate Tumor Inducing Gene in the sample, wherein a positive detection of the expression indicates the presence of cancer cells in the sample. In an embodiment, the expression is performed by measuring the level of PTI mRNA. The mRNA is measured by reverse transcription - polymerase chain reaction using at least a pair of appropriate primers. It is well known in the art that once the sequence of the Prostate Tumor Inducing Gene is determined, appropriate pair of primers may be selected. This invention also provides the above method, wherein the expression is performed by measuring the level of PTI protein. The level of PTI protein is measured by steps of: a) contacting the sample with antibody capable of specifically recognizing PTI-1 protein under conditions permitting formation of complexes between the PTI-1 protein and the antibody; and b) measuring the complex formed, thereby measuring the level of PTI-1 protein expressed in the cancer cells.
Patent AU-4187097-A (AU)
Title: Taxoids, preparation thereof and pharmaceutical compositions containing same
Inventor: BOUCHARD HERVE
IPC: C07D305/14
Filed: 1997-10-16
Abstract: New taxoids of general formula (I), their preparation and pharmaceutical compositions containing them. In general formula (I), Ar represents an aryl radical, R represents a hydrogen atom or an acetyl, alkoxyacetyl or alkyl radical, R<SUB>1 </SUB>represents a benzoyl radical or a radical of formula R<SUB>2</SUB>-O-CO- in which R<SUB>2 </SUB>represents an optionally substituted alkyl radical, an alkenyl, alkynyl, cycloalkyl, cycloalkenyl, bicycloalkyl, phenyl or heterocyclyl radical. The new products of general formula (I) have a remarkable antitumor activity.
Patent AU-4256885-A (AU)
Title: Polymer-coated polyisocyanate
Inventor: GROGLER GERHARD
IPC: B01J13/02
Filed: 1985-05-16
Abstract: This invention relates to the production of polymer-coated, finely divided polyisocyanates by mixing (A) solid, finely divided polyisocyanates (preferably dimeric diisocyanates or urea diisocyanates) with (B) polyisocyanates differing in composition from those mentioned under (A) (preferably (cyclo) aliphatic polyisocyanates, such as biuretized diisocyanates or trimers or NCO-prepolymers), in quantities of from 0.05 to 50 parts by weight, and preferably in quantities of from 0.2 to 25 parts by weight, of (B) per 100 parts by weight of (A). The solid polyisocyanate particles surface-modified by covering with polyisocyanates (B) and then reacted with (D) isocyanate-reactive compounds containing reactive hydrogen atoms or with compounds free from active hydrogen atoms which form polymers with isocyanates in sub-equivalent to substantially equivalent quantities (preferably 0.5 to 1.0 equivalent per NCO-equivalent), in the presence of (C) inert, weakly polar organic solvents, (for example aliphatic hydrocarbons or relatively long chain dialkyl ethers), plasticizers, polyols or aromatic polyamines. A polymer coating is formed by the reaction of (B) and (D) around the solid polyisocyanate cores (A). The present invention also relates to the polyisocyanate particles covered with polyisocyanates (B) on the surface of the solid polyisocyanates (A) and, in particular, to the foreign-polymer coated, finely particulate polyisocyanates of retarded reactivity obtained by reaction with (D). The present invention also relates to the use of the polyisocyanate-covered and, more particularly, polymer-coated polyisocyanates, optionally in suspension in polyols and/or plasticizers, for the production of polyurethanes, more particularly in one-component polyurethane reactive systems having a long shelf life and a high thickening point.